Title : Clinical trial design and patient demographics of the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) study program: cardiovascular outcomes with etoricoxib versus diclofenac in patients with osteoarthritis and rheumatoid arthritis.

Pub. Date : 2006 Aug

PMID : 16875903






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The MEDAL program is designed to provide a precise estimate of the relative cardiovascular event rates with the COX-2 selective inhibitor etoricoxib in comparison to the traditional NSAID diclofenac in patients with osteoarthritis and rheumatoid arthritis. Etoricoxib prostaglandin-endoperoxide synthase 2 Homo sapiens